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Abstract This case report presents an incidental ﬁnding of
a rectal GIST (gastrointestinal stromal tumor) presenting as
a submucosal calculus, not previously reported. A 53-year-
old man without a signiﬁcant medical history presented with
abdominalpainintheleftlowerquadrant,andwithconstipa-
tion. Upon rectal examination, a hard submucosal swelling
was palpated 4 cm from the anus, at 3 o’clock, in the left
rectum wall. X-ray photos, computerized tomography (CT)-
scan and a magnetic resonance imaging (MRI) scan clearly
showed a calculus. Excision revealed a turnip-like lesion,
3.1×2.3×1.8 cm. Analysis showed it was a rectal GIST, a
rare mesenchymal tumor of the gastrointestinal tract, which
expressed CD117 (or c-kit, a marker of kit-receptor tyrosine
kinase) and CD34. Calciﬁcation is not a usual clinicopatho-
logical feature of GISTs [1–3], and although a number of
rectal GISTs have been reported [4–9], we have found no
cases so far of rectal GIST presenting as a submucosal cal-
culus.
In general, GISTs are rare mesenchymal tumors of the
gastrointestinal tract (nerve tissue, smooth muscle). Histol-
ogy and immunohistochemistry discriminate gastrointesti-
nal stromal tumors from leiomyomas and neurinomas. The
most important location is the stomach; the rectal location is
rare. Usually, the classic signs of malignancy such as cellu-
lar invasion and metastasis are missing. A set of histologic
criteria stratiﬁes GIST for risk of malignant behavior such
as mitotic activity and tumor size, cellular pleomorphism,
developmental stage of the cell and quantity of cytoplasma
[7,13]. Tumors with a high mitotic activity and size above
5 cm are considered malignant. Recent pharmacological ad-
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vances such as tyrosine kinase inhibitors have determined
c-kit (i.e., CD117) as the most important marker, amongst
others. C-kit positive tumors respond extremely well to
chemotherapy with Imatinib (Glivec r ,G l e e v e cr )[ 10–12].
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Case Report
A 53-year-old man without signiﬁcant medical history pre-
sented with abdominal pain in the left lower quadrant and
constipation. He got up that morning with a cramping ab-
dominal ache that lasted over the day. He was nauseous,
had vomited once, and ructus was present. There had been a
small amount of hard stool and discomfort during defecation
initially, but after the general practitioner had administered
laxatives, he had liquid diarrhea. There was no complaint
of constipation on a regular basis; this was a new ﬁnding.
Tenesmus was absent. There was no bleeding or mucous
discharge. He was feverish, with a temperature of 38.2◦C.
On examination, the abdomen was slightly distended. Aus-
cultation showed diminished intestinal peristalsis, without
borborygmi, and percussion was tympanic. Upon palpation,
the abdomen was supple: there was no reﬂex rigidity nor
guarding, and no rebound tenderness. Upon rectal examina-
tion, a hard submucosal swelling was palpated 4 cm from
the anus, at 3 o’clock, in the left rectum wall. At the time,
this was considered an accidental ﬁnding that was to be in-
vestigated later.
There were no speciﬁc deviations in the lab results. Ultra-
sound investigation displayed some hydronephrosis of the
left kidney and a stone (size: 0.13×0.7 cm) of the left
ureter. X-ray photos displayed a spherical lesion, projecting
inthepelvisandsituatedintherectum,andsomephleboliths
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Fig.1 X-rayphotoshowing therectalcalculusprojectinginthepelvis
(thick arrow) above the pubic symphysis and the phleboliths projecting
on the left colon (thin arrow)
projecting on the left colon, but not the ureter stone
(Fig. 1). Proctoscopy was not conclusive, so further inves-
tigation was performed. A computerized tomography (CT)
scan and a magnetic resonance imaging (MRI) scan also
clearly showed the submucosal calculus (Figs. 2 and 3).
Our patient was diagnosed with abdominal pain and con-
stipationbasedonaureterstoneandslighthydronephrosisof
theleftkidney,withcoincidentalﬁndingofarectaltumor.He
was sent home with adequate analgesia and spontaneously
releasedtheureterstone.Anappointmentwasmadeforelec-
tive excision of the rectal calculus. Transanal excision was
performed in the operating room (Fig. 4) and revealed a
turnip-like lesion, dimensions 3.1×2.3×1.8 cm (Fig. 5).
No normal tissue margins were excised because the tumor
was not connected to the surrounding tissues. After surgery,
the patient went home and recovered well, without any fur-
ther complaints or complications.
Fig. 2 Computerized tomography (CT) scan showing the rectal cal-
culus in the center (arrow)
Fig. 3 Magnetic resonance imaging (MRI) scan. The arrow shows the
rectal calculus in the rectum wall
Fig. 4 Excision of the rectal calculus in the operating room
Fig. 5 Excision revealed a turnip-like lesion, dimensions 3.1×
2.3×1.8 cm
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Table I Prognosis of primary GIST
Risk Size (cm) Mitotic count (per 50 HPF)
Very low risk <2 <5
Low risk 2–5 <5
Intermediate risk <5 6–10
5–10 <5
High risk >5 >5
>10 >Any mitotic rate
Any tumor >10
Note. from Fletcher et al (13). Abbreviations: HPF, high-power ﬁeld.
The calculus was analyzed and consisted of ﬁbroid and
bony tissue, together with bundles of spindle-shaped cells
with cigar-like nuclei. A partially calciﬁed leiomyoma was
considered at ﬁrst, but supplementary immunoperoxidase
analysis showed that the spindle-shaped cells were positive
for CD117 (c-kit) and CD34. Unfortunately, histopathologic
slides showing CD117 staining are not available to us. There
was some focally positive smooth muscle actin, and MIB1
expression appeared negative. The mitotic count was low:
fewer than ﬁve mitoses per 50 HPF. Only then did this anal-
ysis lead to the conclusion of rectal GIST, with extended
calciﬁcation and ossiﬁcation. It was classiﬁed as low-risk
GIST because of the size (between 2 and 5 cm) and low
mitotic count (Table 1).
Conclusion
Calciﬁcation is not a usual clinicopathologic feature of
GISTs [1–3], and although a number of rectal GISTs have
been reported, we have found no cases so far of rectal GIST
presenting as a submucosal calculus. Furthermore, in the
literature we found no cases of calciﬁed GIST in other
sites of the body. Expression of CD117 (c-kit) and CD34
proved that our calculus was in fact a rectal GIST. Calciﬁ-
cation might be explained by internal bleeding of the tumor.
The abdominal pain of our patient could be explained en-
tirely by the ureteral stone. The rectal tumor might only
explain the constipation. Because of the unpredictable bio-
logicalbehaviorofgastrointestinalstromaltumors,theprog-
nosis for our patient is uncertain, in spite of the low-risk
character. For this reason, at multidisciplinary oncological
deliberation, an expectant policy with regular follow-up was
arranged.
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